Effects of intranasal oxytocin on amygdala reactivity to emotional faces in recently trauma-exposed individuals

Social Cognitive and Affective Neuroscience

Volumn 11, Issue 2, 2015, Pages 327-336

  Frijling, Jessie L ^a   van Zuiden, Mirjam ^a   Koch, Saskia B J ^a   Nawijn, Laura ^a   Veltman, Dick J ^b   Olff, Miranda ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ARQ PSYCHOTRAUMA EXPERT GROUP   (Netherlands)

Author keywords

amygdala; Oxytocin; prevention; PTSD; sex differences; trauma

Indexed keywords

OXYTOCIN;

ADULT; AMYGDALA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EMOTION; FACIAL EXPRESSION; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADULT; AMYGDALA; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYTOCIN; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 84960090245     PISSN: 17495016     EISSN: 17495024     Source Type: Journal    
DOI: 10.1093/scan/nsv116     Document Type: Article

References (74)

1. Acheson, D., Feifel, D., de Wilde, S., Mckinney, R., Lohr, J., Risbrough, V. (2013). The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology, 229(1), 199-208.
2. Admon, R., Milad, M.R., Hendler, T. (2013). A causal model of post-traumatic stress disorder: disentangling predisposed from acquired neural abnormalities. Trends in Cognitive Sciences, 17(7), 337-47.
3. Admon, R., Lubin, G., Rosenblatt, J.D., et al. (2012). Imbalanced neural responsivity to risk and reward indicates stress vulnerability in humans. Cerebral Cortex, 23(1), 28-35.
4. Admon, R., Lubin, G., Stern, O., et al. (2009). Human vulnerability to stress depends on amygdala's predisposition and hippocampal plasticity. Proceedings of the National Academy of Sciences of the United States of America, 106(33), 14120-5.
5. American Psychiatric Association. (2000). DSM-IV-TR: Diagnostic and statistical manual of mental disorders, 4th edition, text revision Washington, DC: American Psychiatric Association.
6. Amos, T., Stein, D.J., Ipser, J.C. (2014). Pharmacological interventions for preventing post-traumatic stress disorder (PTSD). The Cochrane Database of Systematic Reviews, 7, CD006239.
7. Bartz, J., Simeon, D., Hamilton, H., et al. (2011). Oxytocin can hinder trust and cooperation in borderline personality disorder. Social Cognitive and Affective Neuroscience, 6(5), 556-63.
8. Bartz, J.A., Zaki, J., Bolger, N., Ochsner, K.N. (2011). Social effects of oxytocin in humans: context and person matter. Trends in Cognitive Sciences, 15(7), 301-9.
9. Bertsch, K., Gamer, M., Schmidt, B., et al. (2013). Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. American Journal of Psychiatry, 170(10), 1169-77.
10. Blake, D.D., Weathers, F.W., Nagy, L.M., et al. (1995). The development of a Clinician-Administered PTSD Scale. Journal of Traumatic Stress, 8(1), 75-90.
11. Brett, M., Anton, J., Valabregue, R., Poline, J. (2002). Region of interest analysis using the MarsBar toolbox for SPM 99. NeuroImage, 16(2), S497.
12. Brewin, C.R., Rose, S., Andrews, B., et al. (2002). Brief screening instrument for post-traumatic stress disorder. The British Journal of Psychiatry, 181, 158-62.
13. Burghardt, N., Bauer, E. (2013). Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits. Neuroscience, 247, 253-72.
14. Caldwell, J.D., Walker, C.H., Pedersen, C.A., Baraka, A.S., Mason, G.A. (1994). Estrogen increases affinity of oxytocin receptors in the medial preoptic area-anterior hypothalamus. Peptides, 15(6), 1079-84.
15. Cardoso, C., Ellenbogen, M.A., Orlando, M.A., Bacon, S.L., Joober, R. (2012). Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology, 38(3), 399-407.
16. Chini, B., Leonzino, M., Braida, D., Sala, M. (2013). Learning about oxytocin: pharmacologic and behavioral issues. Biological Psychiatry, 76(5), 360-6.
17. Cohen, H., Kaplan, Z., Kozlovsky, N., Gidron, Y., Matar, M.A., Zohar, J. (2010). Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses. Journal of Neuroendocrinology, 22(8), 889-904.
18. de Vries, G.J., Olff, M. (2009). The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands. Journal of Traumatic Stress, 22(4), 259-67.
19. Delahanty, D.L., Gabert-Quillen, C., Ostrowski, S.A., et al. (2013). The efficacy of initial hydrocortisone administration at preventing posttraumatic distress in adult trauma patients: a randomized trial. CNS Spectrums, 18(2), 103-11.
20. Derntl, B., Habel, U., Windischberger, C., et al. (2009). General and specific responsiveness of the amygdala during explicit emotion recognition in females and males. BMC Neuroscience, 10, 91.
21. deRoon-Cassini, T., Taubitz, L., Larson, C. (2014). Prediction of chronic PTSD using early fMRI evidence of emotion dysregulation in trauma survivors. Biological Psychiatry, 75(9), 169S.
22. Dodhia, S., Hosanagar, A., Fitzgerald, D.A., et al. (2014). Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder. Neuropsychopharmacology, 39(9), 2061-9.
23. Domes, G., Kumbier, E., Heinrichs, M., Herpertz, S.C. (2014). Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with asperger syndrome. Neuropsychopharmacology, 39(3), 698-706.
24. Domes, G., Heinrichs, M., Kumbier, E., Grossmann, A., Hauenstein, K., Herpertz, S.C. (2013). Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder. Biological Psychiatry, 74(3), 164-71.
25. Domes, G., Heinrichs, M., Glascher, J., Buchel, C., Braus, D.F., Herpertz, S.C. (2007). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biological Psychiatry, 62(10), 1187-90.
26. Domes, G., Lischke, A., Berger, C., et al. (2010). Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology, 35(1), 83-93.
27. Eckstein, M., Becker, B., Scheele, D., et al. (2014). Oxytocin facilitates the extinction of conditioned fear in humans. Biological Psychiatry, 78(3), 194-202.
28. Eickhoff, S.B., Stephan, K.E., Mohlberg, H., et al. (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage, 25(4), 1325-35.
29. Etkin, A., Klemenhagen, K.C., Dudman, J.T., et al. (2004). Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron, 44(6), 1043-55.
30. Feifel, D., Macdonald, K., Nguyen, A., et al. (2010). Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biological Psychiatry, 68(7), 678-80.
31. Feldman, R., Vengrober, A., Ebstein, R. (2014). Affiliation buffers stress: cumulative genetic risk in oxytocin-vasopressin genes combines with early caregiving to predict PTSD in war-exposed young children. Translational Psychiatry, 4(3), e370.
32. Frijling, J.L., van Zuiden, M., Koch, S.B., et al. (2014). Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial. BMC Psychiatry, 14(1), 92.
33. Fusar-Poli, P., Placentino, A., Carletti, F., et al. (2009). Functional atlas of emotional faces processing: a voxelbased meta-analysis of 105 functional magnetic resonance imaging studies. Journal of Psychiatry & Neuroscience, 34(6), 418-32.
34. Gamer, M., Zurowski, B., Buchel, C. (2010). Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proceedings of the National Academy of Sciences of the United States of America, 107(20), 9400-5.
35. Grillon, C., Krimsky, M., Charney, D.R., Vytal, K., Ernst, M., Cornwell, B. (2013). Oxytocin increases anxiety to unpredictable threat. Molecular Psychiatry, 18(9), 958.
36. Grimm, S., Pestke, K., Feeser, M., et al. (2014). Early life stress modulates oxytocin effects on limbic system during acute psychosocial stress. Social Cognitive and Affective Neuroscience, 9(11), 1828-35.
37. Guzmán, Y.F., Tronson, N.C., Jovasevic, V., et al., (2013). Fearenhancing effects of septal oxytocin receptors. Nature Neuroscience, 16, 1185-7.
38. Guzmán, Y.F., Tronson, N.C., Sato, K., et al. (2014). Role of oxytocin receptors in modulation of fear by social memory. Psychopharmacology, 231, 2097-105.
39. Huber, D., Veinante, P., Stoop, R. (2005). Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science, 308(5719), 245-8.
40. Kessler, R.C. (2000). Posttraumatic stress disorder: the burden to the individual and to society. Journal of Clinical Psychiatry, 61(Suppl 5), 4-12.
41. Koch, S. B. J., Van Zuiden, M., Nawijn, L., Frijling, J. L. & Veltman, D. J. (2015). Intranasal Oxytocin Administration Dampens Amygdala Reactivity Towards Emotional Faces in Male and Female PTSD Patients. Neuropsychopharmacology. doi: 10.1038/npp.2015.299.
42. Kirsch, P., Esslinger, C., Chen, Q., et al. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. The Journal of Neuroscience, 25(49), 11489-93.
43. LaBar, K.S., Gatenby, J.C., Gore, J.C., LeDoux, J.E., Phelps, E.A. (1998). Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron, 20(5), 937-45.
44. Labuschagne, I., Phan, K.L., Wood, A., et al. (2010). Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology, 5(12), 2403-213.
45. Langner, O., Dotsch, R., Bijlstra, G., Wigboldus, D.H., Hawk, S.T., van Knippenberg, A. (2010). Presentation and validation of the Radboud Faces Database. Cognition and Emotion, 24(8), 1377-88.
46. LeDoux, J.E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155-84.
47. MacDonald, K., MacDonald, T.M., Brüne, M., et al. (2013). Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression. Psychoneuroendocrinology, 38(12), 2831-43.
48. Macdonald, K., Feifel, D. (2014). Oxytocins role in anxiety: a critical appraisal. Brain Research, 1580, 22-56.
49. Mahan, A.L., Ressler, K.J. (2012). Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends in Neurosciences, 35(1), 24-35.
50. McLaughlin, K.A., Busso, D.S., Duys, A., et al. (2014). Amygdala response to negative stimuli predicts PTSD symptom onset following a terrorist attack. Depression and Anxiety, 31(10), 834-42.
51. Montag, C., Sauer, C., Reuter, M., Kirsch, P. (2013). An interaction between oxytocin and a genetic variation of the oxytocin receptor modulates amygdala activity toward direct gaze: evidence from a pharmacological imaging genetics study. European Archives of Psychiatry and Clinical Neuroscience, 263(2), 169-75.
52. Mouthaan, J., Sijbrandij, M., Reitsma, J.B., Gersons, B.P., Olff, M. (2014). Comparing screening instruments to predict posttraumatic stress disorder. PLoS One, 9(5), e97183.
53. Nishi, D., Matsuoka, Y., Yonemoto, N., Noguchi, H., Kim, Y., Kanba, S. (2010). Peritraumatic distress inventory as a predictor of post-traumatic stress disorder after a severe motor vehicle accident. Psychiatry and Clinical Neurosciences, 64(2), 149-56.
54. Ohlsson, B., Truedsson, M., Bengtsson, M., et al. (2005). Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterology and Motility, 17(5), 697-704.
55. Ostrowski, S.A., Delahanty, D.L. (2014). Prospects for the pharmacological prevention of post-traumatic stress in vulnerable individuals. CNS Drugs, 28(3), 195-203.
56. Ozer, E.J., Best, S.R., Lipsey, T.L., Weiss, D.S. (2003). Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychological Bulletin, 129(1), 52-73.
57. Petrovic, P., Kalisch, R., Singer, T., Dolan, R.J. (2008). Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. The Journal of Neuroscience, 28(26), 6607-15.
58. Pull, C.N., Pull, C.B. (2014). Current status of treatment for posttraumatic stress disorder: focus on treatments combining pharmacotherapy and cognitive-behavioral therapy. International Journal of Cognitive Therapy, 7(2), 149-61.
59. Rose, S., Bisson, J., Churchill, R., Wessely, S. (2002). Psychological debriefing for preventing post-traumatic stress disorder (PTSD). The Cochrane Database of Systematic Reviews, 2, CD000560.
60. Sauer, C., Montag, C., Reuter, M., Kirsch, P. (2013). Imaging oxytocin × dopamine interactions: an epistasis effect of CD38 and COMT gene variants influences the impact of oxytocin on amygdala activation to social stimuli. Frontiers in Neuroscience, 7, 45.
61. Shamay-Tsoory, S.G., Fischer, M., Dvash, J., Harari, H., Perach-Bloom, N., Levkovitz, Y. (2009). Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biological Psychiatry, 66(9), 864-70.
62. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl), 2022-33.
63. Shin, L.M., Rauch, S.L., Pitman, R.K. (2006). Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Annals of the New York Academy of Sciences, 1071, 67-79.
64. Simeon, D., Bartz, J., Hamilton, H., et al. (2011). Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study. Psychoneuroendocrinology, 3(9), 1418-21.
65. Slattery, D.A., Neumann, I.D. (2010). Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology, 58(1), 56-61.
66. Toth, I., Neumann, I.D., Slattery, D.A. (2012). Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner. Psychopharmacology, 223(2), 149-58.
67. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., et al. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage, 15(1), 273-89.
68. van Wingen, G.A., Geuze, E., Vermetten, E., Fernandez, G. (2011). Perceived threat predicts the neural sequelae of combat stress. Molecular Psychiatry, 16(6), 664-71.
69. van Zuiden, M., Kavelaars, A., Geuze, E., Olff, M., Heijnen, C.J. (2013). Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions. Brain, Behavior, and Immunity, 30, 12-21.
70. Walters, J.T., Bisson, J.I., Shepherd, J.P. (2007). Predicting posttraumatic stress disorder: validation of the trauma screening questionnaire in victims of assault. Psychological Medicine, 37(1), 143-50.
71. Wigton, R., Radua, J., Allen, P., et al. (2015). Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. Journal of Psychiatry & Neuroscience, 40(1), E1-22.
72. Zohar, J., Juven-Wetzler, A., Sonnino, R., Cwikel-Hamzany, S., Balaban, E., Cohen, H. (2011a). New insights into secondary prevention in post-traumatic stress disorder. Dialogues in Clinical Neuroscience, 13(3), 301-9.
73. Zohar, J., Yahalom, H., Kozlovsky, N., et al. (2011b). High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies. European Neuropsychopharmacology, 21(11), 796-809.
74. Zoicas, I., Slattery, D.A., Neumann, I.D. (2014). Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum. Neuropsychopharmacology, 39(13), 3027-35.